Bewersdorf, Jan Philipp, Tariq Kewan, Luca Lanino, Ondrej Blaha, Yiwen Liu, Jessica M. Stempel, Najla H. Al Ali, Amy E. DeZern, Mikkael A. Sekeres, Geoffrey L. Uy, Samuel Urrutia, Hetty E. Carraway, Pinkal Desai, Elizabeth A. Griffiths, Eytan M. Stein, Andrew M. Brunner, Christine McMahon, Rory M. Shallis, Joshua F. Zeidner, Michael R. Savona, Hayley Hawkins, Namrata Sonia Chandhok, Constantine Logothetis, Aram Bidikian, Ted M. Getz, Gail J. Roboz, Benjamin Rolles, Eunice S. Wang, Amyah C. Harris, Maria L. Amaya, Somedeb Ball, Justin Grenet, Zhuoer Xie, Yazan F. Madanat, Yasmin Abaza, Talha Badar, Jaclynn Campos, Torsten Haferlach, Jaroslaw P. Maciejewski, David Sallman, Rahul S. Vedula, H. Moses Murdock, Harrison K. Tsai, Evan C. Chen, Lionel Ades, R. Coleman Lindsley, Anoop Enjeti, Kamal Al-Rabi, Khalid Halahleh, Devendra Hiwase, Maria Diez-Campelo, David Valcarcel, Claudia Haferlach, Lisa Pleyer, Ioannis Kotsianidis, Vassiliki Pappa, Valeria Santini, Angela Consagra, Aref Al-Kali, Seishi Ogawa, Yasuhito Nannya, Matteo Giovanni Della Porta, Rami S. Komrokji, Maximilian Stahl, and Amer M. Zeidan. 2020. “Validation of the International Working Group 2023 Response Criteria for Higher Risk Myelodysplastic syndromes/Neoplasms Using the International Consortium for Myelodysplastic Syndromes VALIDATE Database and a Randomized Phase III Trial”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2026.301314.